Article
18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 1 Mar 2015
Kobylecki Christopher, Langheinrich Tobias, Hinz Rainer, Vardy Emma R L C, Brown Gavin, Martino María-Elena, Haense Cathleen, Richardson Anna M, Gerhard Alexander, Anton-Rodriguez Jose M, Snowden Julie S, Neary David, Pontecorvo Michael J, Herholz Karl
Abstract excerpt
UNLABELLED: Pathologic deposition of amyloid β (Aβ) protein is a key component in the pathogenesis of Alzheimer disease (AD) but not a feature of frontotemporal dementia (FTD). PET ligands for Aβ protein are increasingly used in diagnosis and research of dementia syndromes. Here, we report a PET study using (18)F-florbetapir in healthy controls and patients with AD and FTD. METHODS: Ten healthy controls (mean age...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
